StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
51
This year
4
Publishing Date
2024 - 03 - 09
1
2024 - 03 - 06
1
2024 - 02 - 26
1
2024 - 02 - 06
1
2023 - 12 - 26
1
2023 - 12 - 13
1
2023 - 12 - 12
1
2023 - 12 - 08
1
2023 - 11 - 10
1
2023 - 11 - 07
1
2023 - 11 - 02
1
2023 - 11 - 01
1
2023 - 10 - 31
1
2023 - 10 - 24
1
2023 - 10 - 22
1
2023 - 10 - 20
1
2023 - 10 - 16
1
2023 - 10 - 06
1
2023 - 09 - 20
1
2023 - 09 - 10
1
2023 - 09 - 01
1
2023 - 08 - 26
1
2023 - 08 - 21
1
2023 - 06 - 21
1
2023 - 06 - 04
1
2023 - 05 - 30
1
2023 - 05 - 09
1
2023 - 05 - 08
1
2023 - 04 - 19
1
2023 - 03 - 07
1
2023 - 03 - 01
1
2023 - 02 - 22
1
2023 - 01 - 31
2
2022 - 12 - 13
2
2022 - 12 - 01
1
2022 - 11 - 07
1
2022 - 11 - 06
1
2022 - 10 - 20
1
2022 - 10 - 12
1
2022 - 09 - 12
1
2022 - 09 - 11
1
2022 - 09 - 08
1
2022 - 08 - 30
2
2022 - 08 - 29
1
2022 - 08 - 23
1
2022 - 08 - 08
1
2022 - 08 - 07
1
2022 - 08 - 04
1
Sector
Finance
3
Health technology
51
N/a
34
Professional, scientific, and technical services
1
Tags
Acquire
1
Acquisition
3
Advanced
1
Application
2
Approval
1
Asco
1
Association
1
Biosimilar
2
Biotech-bay
6
Biotech-beach
2
Blincyto
2
Blood
1
Bone
1
Cancer
6
Candidate
1
Cardiovascular
2
Cell
2
Clinical-trials-phase-ii
1
Clinical-trials-phase-iii
2
Collaboration
1
Disease
1
Earnings
1
Events
3
Fda
3
Fda-approvals
1
Financial
3
First
1
Grants
2
Humira
1
Ipo
1
Krystexxa
1
Leukemia
2
Lumakras
8
Lung
4
Meeting
1
N/a
34
Network
1
Otezla
4
Patent
1
Phase 1
1
Phase 2
2
Pipeline
2
Plus
2
Positive
4
Potential
1
Prolia
1
Repatha
2
Report
1
Research
6
Resolve
1
Response
1
Results
4
Review
1
Risk
2
Show
1
Soliris
1
Study
2
Therapeutics
3
Trial
2
Year
2
Entities
Abbott laboratories
4
Akebia therapeutics, inc.
3
Amgen inc.
51
Anaptysbio, inc.
1
Astrazeneca plc
2
Beigene, ltd.
50
Bristol-myers squibb company
2
Celldex therapeutics, inc.
1
Chemocentryx, inc.
124
Codexis, inc.
1
Horizon therapeutics public limited company
1
Immuneering corp class a
1
Immunovant, inc.
3
Johnson & johnson
1
Morgan stanley
3
Novartis ag
1
Novo nordisk a/s
1
Pfizer, inc.
1
Provention bio, inc.
2
Regeneron pharmaceuticals, inc.
2
Sanofi
2
Sotera health company
1
Tscan therapeutics inc
1
Vaxart, inc.
1
Xencor, inc.
3
Symbols
ABBV
165
ABT
37
ADAP
9
ADCT
8
AGIO
12
ALNY
11
ALPMF
31
ALPMY
31
AMGN
742
AVEO
10
AZN
106
AZNCF
94
BAX
22
BCRX
13
BDX
9
BEIGF
37
BGNE
117
BHC
19
BIIB
49
BMRN
8
BMY
86
BPMC
12
CCXI
51
CLVS
10
CS
8
ENTX
35
EPZM
10
EXEL
12
GILD
35
GLAXF
98
GMAB
11
GNMSF
11
GSK
110
ILMN
15
INCY
12
JNJ
94
KPTI
12
LLY
88
MDT
17
MS
10
NSC
10
NVO
17
NVS
196
NVSEF
168
OMER
14
OTIC
14
PFE
34
REGN
27
RIGL
11
SNY
170
SNYNF
132
TAK
23
TEVJF
83
TMO
21
UCBJF
10
UCBJY
10
VSTM
10
VTRS
37
XERS
11
YMAB
11
Exchanges
Nasdaq
51
Nyse
5
Crawled Date
2024 - 03 - 09
1
2024 - 03 - 06
1
2024 - 02 - 26
1
2024 - 02 - 06
1
2023 - 12 - 26
1
2023 - 12 - 13
1
2023 - 12 - 12
1
2023 - 12 - 08
1
2023 - 11 - 10
1
2023 - 11 - 07
1
2023 - 11 - 02
1
2023 - 11 - 01
1
2023 - 10 - 31
1
2023 - 10 - 24
1
2023 - 10 - 22
1
2023 - 10 - 20
1
2023 - 10 - 16
1
2023 - 10 - 06
1
2023 - 09 - 20
1
2023 - 09 - 10
1
2023 - 09 - 01
1
2023 - 08 - 26
1
2023 - 08 - 21
1
2023 - 06 - 21
1
2023 - 06 - 04
1
2023 - 05 - 30
1
2023 - 05 - 09
1
2023 - 05 - 08
1
2023 - 04 - 19
1
2023 - 03 - 08
1
2023 - 03 - 01
1
2023 - 02 - 22
1
2023 - 01 - 31
2
2022 - 12 - 14
1
2022 - 12 - 13
1
2022 - 12 - 01
1
2022 - 11 - 07
2
2022 - 10 - 20
1
2022 - 10 - 12
1
2022 - 09 - 12
2
2022 - 09 - 08
1
2022 - 08 - 30
2
2022 - 08 - 29
1
2022 - 08 - 23
1
2022 - 08 - 08
1
2022 - 08 - 07
1
2022 - 08 - 04
1
Crawled Time
00:00
3
01:00
2
08:00
1
09:00
1
11:00
1
12:00
1
12:20
3
12:30
1
13:00
1
13:20
1
13:30
1
14:00
8
14:20
2
15:00
2
16:00
1
16:20
3
18:00
2
19:00
3
20:00
4
20:20
1
21:00
7
22:00
1
23:00
1
Source
ir.chemocentryx.com
1
www.biospace.com
17
www.globenewswire.com
1
www.prnewswire.com
32
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
entities :
Amgen inc.
symbols :
Ccxi
save search
AMGEN PRESENTS NEW RESEARCH ON OTEZLA® (APREMILAST) AT AAD 2024
Published:
2024-03-09
(Crawled : 20:20)
- prnewswire.com
BEIGF
|
$14.29
-9.87%
2.1K
|
n/a
|
Email alert
Add to watchlist
CCXI
|
$51.99
-0.04%
|
Health Technology
|
Email alert
Add to watchlist
BGNE
|
$129.51
-1.86%
-1.89%
300K
|
Health Technology
|
Email alert
Add to watchlist
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
Email alert
Add to watchlist
otezla
research
AMGEN ANNOUNCES 2024 SECOND QUARTER DIVIDEND
Published:
2024-03-06
(Crawled : 21:00)
- prnewswire.com
BGNE
|
$129.51
-1.86%
-1.89%
300K
|
Health Technology
|
-18.81%
|
O:
-0.93%
H:
3.2%
C:
2.66%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-2.77%
|
O:
-0.1%
H:
0.18%
C:
-1.25%
AMGEN OPENS STATE-OF-THE-ART BIOMANUFACTURING SITE IN CENTRAL OHIO
Published:
2024-02-26
(Crawled : 14:00)
- prnewswire.com
BGNE
|
$129.51
-1.86%
-1.89%
300K
|
Health Technology
|
-16.49%
|
O:
2.6%
H:
1.87%
C:
0.7%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-7.0%
|
O:
-0.31%
H:
0.55%
C:
-0.66%
AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS
Published:
2024-02-06
(Crawled : 21:00)
- prnewswire.com
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-0.67%
|
O:
-0.14%
H:
0.35%
C:
-1.12%
XNCR
|
$18.385
-2.98%
-3.07%
830K
|
Health Technology
|
-3.82%
|
O:
-0.05%
H:
0.0%
C:
-2.09%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-0.49%
|
O:
1.33%
H:
0.0%
C:
0.0%
BGNE
|
$129.51
-1.86%
-1.89%
300K
|
Health Technology
|
-15.67%
|
O:
-3.53%
H:
1.53%
C:
-0.27%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-14.91%
|
O:
-0.18%
H:
0.0%
C:
-6.22%
year
financial
results
AMGEN PROVIDES REGULATORY UPDATE ON STATUS OF LUMAKRAS® (SOTORASIB)
Published:
2023-12-26
(Crawled : 14:00)
- prnewswire.com
BGNE
|
$129.51
-1.86%
-1.89%
300K
|
Health Technology
|
-26.46%
|
O:
0.36%
H:
1.17%
C:
-0.59%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-5.36%
|
O:
-0.01%
H:
0.21%
C:
-0.08%
lumakras
update
FDA Grants Priority Review to Amgen's Tarlatamab Application for Advanced Small Cell Lung Cancer
Published:
2023-12-13
(Crawled : 21:00)
- prnewswire.com
BGNE
|
$129.51
-1.86%
-1.89%
300K
|
Health Technology
|
-29.35%
|
O:
0.91%
H:
2.03%
C:
1.4%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-4.51%
|
O:
-0.11%
H:
0.5%
C:
-1.78%
fda
lung
review
cancer
cell
application
grants
advanced
AMGEN ANNOUNCES 2024 FIRST QUARTER DIVIDEND INCREASE TO $2.25 PER SHARE
Published:
2023-12-12
(Crawled : 21:00)
- prnewswire.com
BGNE
|
$129.51
-1.86%
-1.89%
300K
|
Health Technology
|
-27.88%
|
O:
0.25%
H:
2.68%
C:
1.83%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-1.85%
|
O:
0.06%
H:
2.8%
C:
2.72%
first
AMGEN HIGHLIGHTS HEMATOLOGY PORTFOLIO AT ASH 2023
Published:
2023-12-08
(Crawled : 14:00)
- prnewswire.com
BGNE
|
$129.51
-1.86%
-1.89%
300K
|
Health Technology
|
-27.79%
|
O:
-1.32%
H:
0.78%
C:
-1.13%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-0.88%
|
O:
-0.05%
H:
0.3%
C:
-0.76%
AMGEN PRESENTS NEW CARDIOVASCULAR RESEARCH AT AHA 2023
Published:
2023-11-10
(Crawled : 14:00)
- prnewswire.com
BGNE
|
$129.51
-1.86%
-1.89%
300K
|
Health Technology
|
-31.67%
|
O:
2.63%
H:
2.5%
C:
2.35%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
1.84%
|
O:
0.98%
H:
0.49%
C:
0.25%
research
cardiovascular
AMGEN PRESENTS NEW RESEARCH IN EARLY PSORIATIC ARTHRITIS AT ACR 2023
Published:
2023-11-07
(Crawled : 21:00)
- prnewswire.com
BGNE
|
$129.51
-1.86%
-1.89%
300K
|
Health Technology
|
-34.49%
|
O:
0.66%
H:
1.5%
C:
0.61%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-0.8%
|
O:
0.48%
H:
0.86%
C:
0.31%
research
AMGEN PRESENTS NEW DATA THAT SHOW BLOOD PRESSURE DECREASES FOR ADULTS TREATED WITH KRYSTEXXA® (PEGLOTICASE)
Published:
2023-11-02
(Crawled : 14:00)
- biospace.com/
BGNE
|
$129.51
-1.86%
-1.89%
300K
|
Health Technology
|
-28.56%
|
O:
0.5%
H:
2.69%
C:
-0.09%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
3.1%
|
O:
0.94%
H:
1.82%
C:
1.25%
krystexxa
blood
show
AMGEN TO PRESENT DATA AT ACR 2023 ACROSS EXPANDED RHEUMATOLOGY PIPELINE AND PORTFOLIO
Published:
2023-11-01
(Crawled : 20:00)
- biospace.com/
BGNE
|
$129.51
-1.86%
-1.89%
300K
|
Health Technology
|
-30.47%
|
O:
-1.12%
H:
1.26%
C:
-1.57%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
5.17%
|
O:
0.22%
H:
1.92%
C:
1.78%
pipeline
AMGEN REPORTS THIRD QUARTER FINANCIAL RESULTS
Published:
2023-10-31
(Crawled : 11:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
4.76%
|
O:
4.66%
H:
0.0%
C:
-3.51%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-4.53%
|
O:
0.25%
H:
0.54%
C:
0.29%
XNCR
|
$18.385
-2.98%
-3.07%
830K
|
Health Technology
|
6.67%
|
O:
-0.41%
H:
2.1%
C:
1.11%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
4.28%
|
O:
2.61%
H:
0.0%
C:
0.0%
REGN
|
$896.27
0.26%
0.25%
500K
|
Health Technology
|
15.32%
|
O:
-0.33%
H:
0.92%
C:
0.61%
BGNE
|
$129.51
-1.86%
-1.89%
300K
|
Health Technology
|
-30.59%
|
O:
0.14%
H:
0.68%
C:
-0.32%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
2.18%
|
O:
-2.77%
H:
0.6%
C:
-0.07%
financial
results
AMGEN ANNOUNCES 2023 FOURTH QUARTER DIVIDEND
Published:
2023-10-24
(Crawled : 20:00)
- prnewswire.com
BGNE
|
$129.51
-1.86%
-1.89%
300K
|
Health Technology
|
-25.12%
|
O:
-2.79%
H:
2.0%
C:
-0.98%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-2.6%
|
O:
-0.37%
H:
0.58%
C:
-1.07%
AMGEN PRESENTS NEW LUMAKRAS® (SOTORASIB) PLUS VECTIBIX® (PANITUMUMAB) DATA IN PATIENTS WITH KRAS G12C-MUTATED METASTATIC COLORECTAL CANCER
Published:
2023-10-22
(Crawled : 16:20)
- prnewswire.com
CCXI
|
$51.99
-0.04%
|
Health Technology
|
Email alert
Add to watchlist
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
Email alert
Add to watchlist
BGNE
|
$129.51
-1.86%
-1.89%
300K
|
Health Technology
|
Email alert
Add to watchlist
BEIGF
|
$14.29
-9.87%
2.1K
|
n/a
|
Email alert
Add to watchlist
lumakras
cancer
plus
AMGEN PRESENTS NEW TARLATAMAB DATA IN SMALL CELL LUNG CANCER
Published:
2023-10-20
(Crawled : 12:00)
- prnewswire.com
BGNE
|
$129.51
-1.86%
-1.89%
300K
|
Health Technology
|
-18.37%
|
O:
-1.33%
H:
5.87%
C:
5.53%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-4.16%
|
O:
0.0%
H:
0.16%
C:
-0.64%
lung
cancer
cell
AMGEN TO PRESENT NEW RESEARCH FROM ONCOLOGY PORTFOLIO AND PIPELINE AT ESMO 2023
Published:
2023-10-16
(Crawled : 18:00)
- biospace.com/
XNCR
|
$18.385
-2.98%
-3.07%
830K
|
Health Technology
|
-2.49%
|
O:
0.0%
H:
1.49%
C:
0.53%
BGNE
|
$129.51
-1.86%
-1.89%
300K
|
Health Technology
|
-27.56%
|
O:
-3.15%
H:
2.37%
C:
0.45%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-5.34%
|
O:
0.14%
H:
1.16%
C:
0.84%
pipeline
research
AMGEN COMPLETES ACQUISITION OF HORIZON THERAPEUTICS PLC
Published:
2023-10-06
(Crawled : 12:30)
- prnewswire.com
BGNE
|
$129.51
-1.86%
-1.89%
300K
|
Health Technology
|
-24.11%
|
O:
1.62%
H:
1.06%
C:
0.25%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
1.45%
|
O:
-0.73%
H:
2.07%
C:
1.64%
acquisition
therapeutics
AMGEN LAUNCHES PARTNERS OF CHOICE NETWORK OF EIGHT LEADING ONCOLOGY ACADEMIC CENTERS
Published:
2023-09-20
(Crawled : 20:00)
- prnewswire.com
BGNE
|
$129.51
-1.86%
-1.89%
300K
|
Health Technology
|
-32.84%
|
O:
-2.14%
H:
0.25%
C:
-0.49%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-0.93%
|
O:
0.22%
H:
0.15%
C:
-0.98%
network
AMGEN PRESENTS NEW LUMAKRAS® (SOTORASIB) PLUS CHEMOTHERAPY DATA IN FIRST-LINE KRAS G12C NSCLC AT WCLC
Published:
2023-09-10
(Crawled : 16:20)
- prnewswire.com
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
Email alert
Add to watchlist
MS
|
News
0 d
|
$90.66
0.44%
0.07%
8.1M
|
Finance
|
Email alert
Add to watchlist
BGNE
|
$129.51
-1.86%
-1.89%
300K
|
Health Technology
|
Email alert
Add to watchlist
BEIGF
|
$14.29
-9.87%
2.1K
|
n/a
|
Email alert
Add to watchlist
CCXI
|
$51.99
-0.04%
|
Health Technology
|
Email alert
Add to watchlist
lumakras
plus
← Previous
1
2
3
Next →
Gainers vs Losers
67%
33%
Top 10 Gainers
AGBA
|
News
|
$1.26
215.0%
68.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
OLB
4
|
$0.33
-14.95%
25.53%
840K
|
Technology Services
NVFY
|
$2.77
31.28%
23.83%
33M
|
Consumer Durables
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
RCON
|
$0.1112
13.01%
21.28%
1.7M
|
Distribution Services
INSG
|
$3.03
25.21%
20.13%
330K
|
Electronic Technology
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
WLGS
|
$0.59
18.0%
17.9%
2.3M
|
ASNS
|
$0.828
21.75%
17.86%
18K
|
Your saved searches
Save your searches and get alerts when important news are released.